rx pop-outs

Post on 22-Feb-2016

96 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

Rx Pop-Outs. Irina Racheva, Sam Gyory, Briani Boyd , Rian Rendon . Management Team. CEO – Irina Racheva C F O – Sam Gyory C M O – Briani Boyd C O O – Rian Rendon. Company Information. Headquarters: 3110 Georgia Avenue, NW Washington, D.C. 20010 - PowerPoint PPT Presentation

TRANSCRIPT

Rx Pop-Outs Irina Racheva, Sam Gyory, Briani Boyd, Rian

Rendon

Management Team CEO – Irina Racheva CFO – Sam Gyory

CMO – Briani Boyd COO – Rian Rendon

Company Information• Headquarters:

3110 Georgia Avenue, NW Washington, D.C. 20010

• Store: 2324 Pennsylvania Avenue Washington, D.C. 20020

• Contact: (202) 730-5330

• Website: http://rxpopouts.weebly.com/

Product Description• Our revolutionary frames allow you

to instantaneously pop out your lenses from one frame into anothero Plastic frameo Silicone rubber lens rim allows

for the lens switch

• Sale price:o Set of polycarbonate lenses:

$70o Each frame: $65

Irina Racheva
Bri, pls explain what the actual product is before going into cost of production
Briani Boyd
I switched the bullet points and added a little more to the description.

Company Plans• Continue on the same growth trajectory, at least

for the next two years, as demand continues to grow

• Increase market size – to be reached through improved marketing efforts• Increase our presence on the U.S. West Coast • Eventually go global

o Introduce international shippingo Market internationally

• Introduce a wider variety of frames (i.e. colors and styles)

Marketing Plan• Target Audience: Near-sighted individuals, aged 18 - 40

• Marketing Channels:o University Brand Ambassador Program - marketing internships for

college studentso Social Media Advertisements: Facebooko Eye Doctor Endorsements

• Marketing Expenses:o Year 1: $2,000o Year 2: $10,000

• Retail:o Retail store: 2324 Pennsylvania Avenue, Washington D.C.o Online Website: http://rxpopouts.weebly.com/

Irina Racheva
Bri, can you add some pics here and maybe the logos of eye care companies that we supposedly are being endorsed by

Cash Flow Analysis• Cash provided by operating activities:

o Year 1: $683,835o Relatively high due to the company’s purchases on account, rather than with casho A/R also significant (153,337) will contribute to cash growth in the following year

o Year 2: $328,575o The lower cash flow is due to the large amount of A/P ($683,835) paid off o Future cash flow is expected to increase once the start-up costs are entirely accounted

for and paid

Cash Flow Analysis• Cash provided by (used up) by investing activities:

o Year 1: ($509,500) o Purchase of a $500,000 building to serve as an office

o Year 2: ($2,100)o Fewer investment activities as start-up costs were mostly incurred

in Year 1

Cash Flow Analysis• Cash provided by (used by) financing activities:

o Year 1: $1,593,486o Significant cash increase ($1 million) due to stock issuance and undertaking of a

$200,000 long-term debt

o Year 2: ($204,809)o Large amount of cash was used up to repay a portion of the long-term debt

Financial Summary

In U.S. Dollars Year 2 Year 1 YoY GrowthCurrent Assets 2,202,997 2,007,624 9.73%Long-Term Assets 486,757 497,386 -2.14%Total Assets 2,689,754 2,505,010 7.37%Current Liabilities 1,059,064 866,480 22.23%Long-Term Liabilities 486,677 593,486 -18.00%Total Liabilities 1,545,741 1,459,966 5.88%Revenues 1,510,140 1,045,481 44.44%Expenses 1,313,171 1,000,437 31.26%Net Income 196,969 45,044 337.28%

Financial Highlights• Strong, consistent current ratio

• Increasing return on assets

• Increasing return on equity

• Increase in earnings/share

• Declining debt to current ratio – projected to decline more rapidly in 2014

  Year 2 Year 1 YoY ChangeCurrent Ratio 2.08 2.32 -0.24Return on Assets 7.32% 1.80% 5.52%Return on Equity 17.22% 4.31% 12.91%Earnings per Share 6.16 1.13 5.03 Debt to Total Assets Ratio 57.47% 58.28% -0.81%

Thank you.

top related